The long-term outlook for life sciences companies remains strong. Thousands of treatments are being investigated, and spending on pharmaceuticals remains high. Although companies early in their discovery process aren’t getting financing as quickly as happened at the height of the market, overall venture capital funding was $5.6 billion higher last year than in 2023, making 2024 the fourth-best year on record.
...more
RSK: Good news for Velocity Station on Odana Rd.
Share this article on you social outlets
Our Sponsors
- - Volume: 25 - WEEK: 16 Date: 4/15/2025 12:28:56 PM -